The literature supports central albeit complex roles of OPN in regulating autophagic and inflammatory responses to amyloid-beta (Aβ) and tau accumulations in the brain that coincide with AD progression and represent possible new therapeutic targets. This evidence concerns the gene SPP1 and Alzheimer disease.